ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 50 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -83.3% | 50 | -81.1% | 0.00% | – |
| Q2 2018 | $6,000 | 0.0% | 265 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -85.7% | 265 | -78.2% | 0.00% | – |
| Q4 2017 | $42,000 | +61.5% | 1,215 | -2.1% | 0.00% | – |
| Q3 2017 | $26,000 | +1200.0% | 1,241 | +1141.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 100 | +2400.0% | 0.00% | – |
| Q2 2015 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |